Form 8-K - Current report:
SEC Accession No. 0001140361-21-022830
Filing Date
2021-06-30
Accepted
2021-06-30 09:17:03
Documents
37
Period of Report
2021-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10026425_8k.htm 8-K 19229
2 EXHIBIT 99.1 brhc10026425_ex99-1.htm EX-99.1 61392
3 EXHIBIT 99.2 brhc10026425_ex99-2.htm EX-99.2 24116
4 brhc10026425_ex99-1slide1.jpg GRAPHIC 84220
5 brhc10026425_ex99-1slide2.jpg GRAPHIC 376269
6 brhc10026425_ex99-1slide3.jpg GRAPHIC 124004
7 brhc10026425_ex99-1slide4.jpg GRAPHIC 191965
8 brhc10026425_ex99-1slide5.jpg GRAPHIC 178102
9 brhc10026425_ex99-1slide6.jpg GRAPHIC 88210
10 brhc10026425_ex99-1slide7.jpg GRAPHIC 63219
11 brhc10026425_ex99-1slide8.jpg GRAPHIC 104679
12 brhc10026425_ex99-1slide9.jpg GRAPHIC 169487
13 brhc10026425_ex99-1slide10.jpg GRAPHIC 166756
14 brhc10026425_ex99-1slide11.jpg GRAPHIC 177459
15 brhc10026425_ex99-1slide12.jpg GRAPHIC 173319
16 brhc10026425_ex99-1slide13.jpg GRAPHIC 146407
17 brhc10026425_ex99-1slide14.jpg GRAPHIC 139131
18 brhc10026425_ex99-1slide15.jpg GRAPHIC 138177
19 brhc10026425_ex99-1slide16.jpg GRAPHIC 137180
20 brhc10026425_ex99-1slide17.jpg GRAPHIC 170018
21 brhc10026425_ex99-1slide18.jpg GRAPHIC 152028
22 brhc10026425_ex99-1slide19.jpg GRAPHIC 150493
23 brhc10026425_ex99-1slide20.jpg GRAPHIC 138249
24 brhc10026425_ex99-1slide21.jpg GRAPHIC 192356
25 brhc10026425_ex99-1slide22.jpg GRAPHIC 107931
26 brhc10026425_ex99-1slide23.jpg GRAPHIC 220773
27 brhc10026425_ex99-1slide24.jpg GRAPHIC 133894
28 brhc10026425_ex99-1slide25.jpg GRAPHIC 41566
29 brhc10026425_ex99-1slide26.jpg GRAPHIC 163194
30 brhc10026425_ex99-1slide27.jpg GRAPHIC 168491
31 brhc10026425_ex99-1slide28.jpg GRAPHIC 162257
32 brhc10026425_ex99-1slide29.jpg GRAPHIC 150134
33 brhc10026425_ex99-1slide30.jpg GRAPHIC 98938
34 brhc10026425_ex99-1slide31.jpg GRAPHIC 35136
35 brhc10026425_ex99-1slide32.jpg GRAPHIC 207234
36 brhc10026425_ex99-1slide33.jpg GRAPHIC 79529
37 image0.jpg GRAPHIC 6484
  Complete submission text file 0001140361-21-022830.txt   6771676
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 211060569
SIC: 2834 Pharmaceutical Preparations